Oncology Pharmacy Resources

Search ISOPP's Oncology Pharmacy Resources for materials related to oncology pharmacy research and practice including past ISOPP Symposia resources and journal enewsletters. You can search using a key word or on a topic area.

ISOPP members have full access to this resource. Why not join us? Our great range of benefits will help you make powerful connections, enhance your knowledge, and get more from your profession. Find out more here.

Already a member? Login to have access.

Read the Privacy and Terms of Use statement.

Biosimilars: ISOPP Biosimilars Position Statements

This position statement aims to provide the global oncology pharmacy community with guidance to support decisions around biosimilar use. The 11 statements cover the regulation and evaluation of biosimilars, practical issues around local implementation, the education of healthcare staff and patients, and the requirement for ongoing pharmacovigilance and outcome monitoring.

Tools and References

Written by hospital pharmacists for hospital pharmacists, the hub offers free access to a wealth of eLearning materials and modules, on topics relevant to hospital pharmacists, including the latest developments in the safe handling of hazardous drugs. Content is translated into English, French, Spanish, Italian, German and Dutch.

The initiative is funded through an ‘arms-length’ grant from Becton Dickinson. However, all content, direction, marketing and administration is controlled by Cogora, publishers of Hospital Pharmacy Europe.

Are you ready to submit your abstract? The ISOPP Research Committee has prepared a resource on how to write an abstract for a scientific meeting.  A useful tool guiding you in the process of preparing a well-written abstract, especially if it is your first time. Review the guide for some 'tips and tricks'.

A document intended to serve as a guideline during the development of a dose-rounding policy and to support and validate existing policies.

Endorsed by ISOPP as per ISOPP's endorsement guidlines

The purpose of the NCCN Chemotherapy Order Templates is to enhance patient safety by allowing you to standardize patient care, reduce medication errors, and anticipate and manage adverse events. The NCCN Templates include systemic therapies such as chemotherapy and immunotherapy (along with information such as dosing, route of administration, and duration of infusion), supportive care recommendations, monitoring parameters, and safety instructions.

The purpose of this document is to educate healthcare professionals, hematopoietic cell transplant (HCT) program staff, and pharmacy leadership about the specialty role of the HCT clinical pharmacist.

A new FDA website that makes getting information easy. Ph

FDA

USA Food and Drug Administration

ISOPP Webinars

When: Wednesday, September 11, 2019 at 04:00 PTD (Click here to find your local time).

Presented by Carole Chambers (Alberta Health Services, Canada), Michael Cohen (ISMP, USA) and Peter Gilbar (Darling Downs Hospital and Health Service, Australia) 

ISOPP Documents

Would you like to see one of ISOPP's Symposium held in your city or country? Contact services@isopp.org.

1988 to 2012 - compiled by: Helen M McKinnon

ISOPP Newsletter

Newsletter - Volume 22 | No. 2 & 3 | June and September 2020

Newsletter - Vol 22, No. 1. March 2020

Newsletter - Vol 21, No. 4. December 2019

Newsletter - Vol 21, No. 3. September 2019

Newsletter - Vol 21, No. 2. June 2019

Newsletter - Vol 21, No. 1. March 2019

Newsletter - Vol 20, No. 4. December 2018

Newsletter - Vol 20, No. 3. September 2018

Newsletter - Vol 20, No. 2. June 2018

Newsletter - Vol 20, No. 1. May 2018

Newsletter - Vol 19, No. 4. December 2017

Newsletter - Vol 19, No. 3. September 2017

Newsletter - Vol 19, No. 2. June 2017

Newsletter - Vol 19, No. 1. March 2017

Newsletter - Vol 18, No. 4. December 2016

Newsletter - Vol 18, No 3. September 2016

Newsletter - Vol 18, No 2. June 2016

Newsletter - Vol 18, No 1. March 2016

Newsletter - Vol 17, No 4. December 2015

Newsletter - Vol 17, No 3. September 2015

Newsletter - Vol 17, No 2. June 2015

Newsletter - Vol 17, No 1. March 2015

Newsletter - Vol 16, No 4. December 2014

Newsletter - Vol 16, No 3. September 2014

Newsletter - Vol 16, No 2. June 2014

Newsletter - Vol 16, No 1. March 2014

Newsletter - Vol 15, No 4, December 2013

Newsletter - Vol 15, No 3. October 2013

Newsletter - Vol 15, No 2. June 2013

Newsletter - Vol 5, No 1. March 2003

Newsletter - Vol 15, No 1. March 2013

Newsletter - Vol 14, No 4. December 2012

Newsletter - Vol 14, No 3. September 2012

Newsletter - Vol 14, No 2. June 2012

Newsletter - Vol 14, No 1. March 2012

Newsletter - Vol 13, No 4. December 2011

Newsletter - Vol 13, No 3. September 2011

Newsletter - Vol 13, No 2. June 2011

Newsletter - Vol 13, No 1. March 2011

Newsletter - Vol 12, No 4. December 2010

Newsletter - Vol 12, No 2. September 2010

Newsletter - Vol 12, No 2. June 2010

Newsletter - Vol 12, No 1. March 2010

Newsletter - Vol 11, No 4. December 2009

Newsletter - Vol 11, No 3. September 2009

Newsletter - Vol 11, No 2. July 2009

Newsletter - Vol 11, No 1. March 2009

Newsletter - Vol 10, No 3. December 2008

Newsletter - Vol 10, No 2. August 2008

Newsletter - Vol 10, No 1. March 2008

Newsletter - Vol 9, No 4. December 2007

Newsletter - Vol 9, No 3. September 2007

Newsletter - Vol 9, No 2. June 2007

Newsletter - Vol 9, No 1. March 2007

Newsletter - Vol 8, No 4. December 2006

Newsletter - Vol 8, No 3. September 2006

Newsletter - Vol 8, No 2. June 2006

Newsletter - Vol 8, No 1. March 2006

Newsletter - Vol 7, No 4. December 2005

Newsletter - Vol 7, No 3, September 2005

Newsletter - Vol 7, No 2. June 2005

Newsletter - Vol 7, No 1. March 2005

Newsletter - Vol 6, No 4. December 2004

Newsletter - Vol 6, No 3. September 2014

Newsletter - Vol 6, No 2. June 2004

Newsletter - Vol 6, No 1. March 2004

Newsletter - Vol 5, No 2. June 2003

Newsletter - Vol 5, No 3. September 2003

Newsletter - Vol 5, No 4. December 2003

Oncology Pharmacy Resources

The American Society of Clinical Oncology (ASCO) has updated its guidelines to prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer patients.

The purpose of Hematopoietic Stem Cell Transplantation (HSCT) E-learning Tool is to provide basic knowledge to hospital and community pharmacists involved in the pharmaceutical care for HSCT patients.

Become a member to have access!

Designed to help hospitals and ambulatory care centers throughout the world evaluate oncology medication safety

These draft guidelines are open for public consultation from 29 May 2017 to 23 June 2017. 

Provides health professionals with peer-maintained information about best practice in cancer treatment